REPORT ID 10234

Global Blood-Brain Barrier Transport Drugs Sales Market Report 2017

Publish Date
16-Nov-17
Pages
111
Format
Electronic (PDF)

In this report, the global Blood-Brain Barrier Transport Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Blood-Brain Barrier Transport Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Blood-Brain Barrier Transport Drugs market competition by top manufacturers/players, with Blood-Brain Barrier Transport Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Cyclenium
    BioAdvance
    EIP Pharma
    Bioasis
    Immune Pharmaceuticals
    AZ Therapies
    Palobiofarma
    Bach Pharma
    BrainsGate
    CarThera
    Dainippon Sumitomo Pharma
    Fluorinov Pharma
    Fondazione Telethon
    Minoryx
    NewGen Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Carrier-mediated Transport
    Receptor-mediated Transport
    Absorptive-mediated Transport
    Active Efflux Transport
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Alzheimer's Disease
    Epilepsy
    Parkinson's Disease
    Multiple Sclerosis
    Hunter's Syndrome
    Brain Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Blood-Brain Barrier Transport Drugs Sales Market Report 2017
1 Blood-Brain Barrier Transport Drugs Market Overview
    1.1 Product Overview and Scope of Blood-Brain Barrier Transport Drugs
    1.2 Classification of Blood-Brain Barrier Transport Drugs by Product Category
        1.2.1 Global Blood-Brain Barrier Transport Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Blood-Brain Barrier Transport Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Carrier-mediated Transport
        1.2.4 Receptor-mediated Transport
        1.2.5 Absorptive-mediated Transport
        1.2.6 Active Efflux Transport
        1.2.7 Others
    1.3 Global Blood-Brain Barrier Transport Drugs Market by Application/End Users
        1.3.1 Global Blood-Brain Barrier Transport Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Alzheimer's Disease
        1.3.3 Epilepsy
        1.3.4 Parkinson's Disease
        1.3.5 Multiple Sclerosis
        1.3.6 Hunter's Syndrome
        1.3.7 Brain Cancer
        1.3.8 Others
    1.4 Global Blood-Brain Barrier Transport Drugs Market by Region
        1.4.1 Global Blood-Brain Barrier Transport Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
        1.4.3 China Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
        1.4.7 India Blood-Brain Barrier Transport Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Blood-Brain Barrier Transport Drugs (2012-2022)
        1.5.1 Global Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2022)

2 Global Blood-Brain Barrier Transport Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Blood-Brain Barrier Transport Drugs Market Competition by Players/Suppliers
        2.1.1 Global Blood-Brain Barrier Transport Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Blood-Brain Barrier Transport Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Blood-Brain Barrier Transport Drugs (Volume and Value) by Type
        2.2.1 Global Blood-Brain Barrier Transport Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Blood-Brain Barrier Transport Drugs (Volume and Value) by Region
        2.3.1 Global Blood-Brain Barrier Transport Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Blood-Brain Barrier Transport Drugs (Volume) by Application

3 United States Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    3.1 United States Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        3.1.1 United States Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    3.2 United States Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    3.3 United States Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    3.4 United States Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

4 China Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    4.1 China Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        4.1.1 China Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    4.2 China Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    4.3 China Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    4.4 China Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

5 Europe Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    5.1 Europe Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        5.1.1 Europe Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    5.2 Europe Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    5.3 Europe Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    5.4 Europe Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

6 Japan Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    6.1 Japan Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        6.1.1 Japan Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    6.2 Japan Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    6.3 Japan Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    6.4 Japan Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

7 Southeast Asia Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

8 India Blood-Brain Barrier Transport Drugs (Volume, Value and Sales Price)
    8.1 India Blood-Brain Barrier Transport Drugs Sales and Value (2012-2017)
        8.1.1 India Blood-Brain Barrier Transport Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Blood-Brain Barrier Transport Drugs Sales Price Trend (2012-2017)
    8.2 India Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Players
    8.3 India Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Type
    8.4 India Blood-Brain Barrier Transport Drugs Sales Volume and Market Share by Application

9 Global Blood-Brain Barrier Transport Drugs Players/Suppliers Profiles and Sales Data
    9.1 Cyclenium
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 BioAdvance
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 EIP Pharma
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Bioasis
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Immune Pharmaceuticals
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 AZ Therapies
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Palobiofarma
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Bach Pharma
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 BrainsGate
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 CarThera
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Blood-Brain Barrier Transport Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Dainippon Sumitomo Pharma
    9.12 Fluorinov Pharma
    9.13 Fondazione Telethon
    9.14 Minoryx
    9.15 NewGen Therapeutics

10 Blood-Brain Barrier Transport Drugs Maufacturing Cost Analysis
    10.1 Blood-Brain Barrier Transport Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
    10.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Blood-Brain Barrier Transport Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Blood-Brain Barrier Transport Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Blood-Brain Barrier Transport Drugs Market Forecast (2017-2022)
    14.1 Global Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Blood-Brain Barrier Transport Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Blood-Brain Barrier Transport Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Blood-Brain Barrier Transport Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Blood-Brain Barrier Transport Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Blood-Brain Barrier Transport Drugs Sales Volume, Reve